Status:

COMPLETED

Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures

Lead Sponsor:

Medical University of Vienna

Conditions:

Meibomian Gland Dysfunction

Cataract

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The development of optical coherence tomography (OCT) and its application for in vivo imaging has opened entirely new opportunities in ophthalmology. The technology allows for both noninvasive visuali...

Eligibility Criteria

Inclusion

  • For patients with meibomian gland dysfunction (MGD):
  • MGD as evidenced by clinical features and gland expression (MGD Grading Scheme, Appendix I (Opitz, Harthan et al. 2015))
  • For cataract patients:
  • Cataract as evidenced from slit lamp examination, stage range between NII-NIII, CII-CIV, PII-PIII according to The Lens Opacity Classification System II (LOCS II) (Chylack, Leske et al. 1989) (Appendix II)
  • For patients after minimally invasive glaucoma surgery (MIGS):
  • Patients with history of MIGS secondary to glaucoma
  • For patients with demodicosis:
  • Demodicosis as evidenced from slit lamp examination and presence of Demodex confirmed by microscopic examination of the eye lashes (Liu, Sheha et al. 2010)
  • For patients with conjunctival pathologies (cyst, naevus, pterygium):
  • Conjunctival pathologies with a clinical diagnosis of the respective
  • For patients with Acanthamoeba keratitis:
  • Acanthamoeba keratitis as evidenced from slit lamp examination and confirmed by polymerase chain reaction (PCR) analysis of corneal epithelial and tear samples and culture isolation (Lehmann, Green et al. 1998)
  • For aniridia patients:
  • Anirida as evidenced from slit lamp examination

Exclusion

  • Presence of any abnormalities preventing reliable measurements as judged by the investigator
  • Pregnancy, planned pregnancy or lactating

Key Trial Info

Start Date :

July 12 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 16 2023

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT03461978

Start Date

July 12 2017

End Date

June 16 2023

Last Update

May 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University Vienna, Department of Clnical Pharmacology

Vienna, Vienna, Austria, 1090